180 related articles for article (PubMed ID: 17384651)
21. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
[TBL] [Abstract][Full Text] [Related]
23. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
Youssef RF; Shariat SF; Kapur P; Kabbani W; Ghoneim T; King E; Cockburn A; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
Hum Pathol; 2011 Mar; 42(3):347-55. PubMed ID: 21111452
[TBL] [Abstract][Full Text] [Related]
24. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
Margulis V; Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Clin Cancer Res; 2006 Dec; 12(24):7369-73. PubMed ID: 17189409
[TBL] [Abstract][Full Text] [Related]
25. Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.
Kapur P; Lotan Y; King E; Kabbani W; Mitra AP; Mosbah A; Abol-Enein H; Ghoneim M; Youssef RF
Am J Clin Pathol; 2011 Jun; 135(6):822-30. PubMed ID: 21571954
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of p53, p63, c-myc, p21(WAF1/cip1) and p27(kip1) proteins in urothelial bladder carcinoma: correlation with clinicopathological parameters.
Grapsa D; Dokou A; Tsokanou-Kouli V; Kaltsas S; Dalakou E; Trigidou R; Saif MW; Politi E
J BUON; 2014; 19(4):1121-4. PubMed ID: 25536625
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
28. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.
Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS
Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081
[TBL] [Abstract][Full Text] [Related]
29. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
30. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
[TBL] [Abstract][Full Text] [Related]
31. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
Karam JA; Lotan Y; Karakiewicz PI; Ashfaq R; Sagalowsky AI; Roehrborn CG; Shariat SF
Lancet Oncol; 2007 Feb; 8(2):128-36. PubMed ID: 17267327
[TBL] [Abstract][Full Text] [Related]
32. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
34. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
35. Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
Tokunaga H; Shariat SF; Green AE; Brown RM; Zhou JH; Benedict WF; Lerner SP
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):16-22. PubMed ID: 11516846
[TBL] [Abstract][Full Text] [Related]
36. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder.
Wang LC; Xylinas E; Kent MT; Kluth LA; Rink M; Jamzadeh A; Rieken M; Al Hussein Al Awamlh B; Trinh QD; Sun M; Karakiewicz PI; Novara G; Chrystal J; Zerbib M; Scherr DS; Lotan Y; Vickers A; Shariat SF
Urol Oncol; 2014 May; 32(4):433-40. PubMed ID: 24433754
[TBL] [Abstract][Full Text] [Related]
37. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
38. Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder.
Park DS; Lee YT; Lee JM
Adv Exp Med Biol; 2003; 539(Pt A):67-85. PubMed ID: 15088897
[TBL] [Abstract][Full Text] [Related]
39. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
40. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
